Krishnamurthy SR, Wang D (2018). “Extensive conservation of prokaryotic ribosomal binding sites in known and novel picobirnaviruses”. Virology516: 108–114. doi:10.1016/j.virol.2018.01.006. PMID29346073.
Kutter, Elizabeth; De Vos, Daniel; Gvasalia, Guram; Alavidze, Zemphira; Gogokhia, Lasha; Kuhl, Sarah; Abedon, Stephen (1 January 2010). “Phage Therapy in Clinical Practice: Treatment of Human Infections”. Current Pharmaceutical Biotechnology11 (1): 69–86. doi:10.2174/138920110790725401. PMID20214609.
Rhoads, DD; Wolcott, RD; Kuskowski, MA; Wolcott, BM; Ward, LS; Sulakvelidze, A (June 2009). “Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial”. Journal of Wound Care18 (6): 237–8, 240–3. doi:10.12968/jowc.2009.18.6.42801. PMID19661847.
Wright, A.; Hawkins, C.H.; Änggård, E.E.; Harper, D.R. (August 2009). “A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy”. Clinical Otolaryngology34 (4): 349–357. doi:10.1111/j.1749-4486.2009.01973.x. PMID19673983.
Mokrousov I (2009). “Corynebacterium diphtheriae: genome diversity, population structure and genotyping perspectives”. Infection, Genetics and Evolution9 (1): 1–15. doi:10.1016/j.meegid.2008.09.011. PMID19007916.
Martin, C. (1988). “The Application of Bacteriophage Tracer Techniques in South West Water”. Water and Environment Journal2 (6): 638–642. doi:10.1111/j.1747-6593.1988.tb01352.x.
Lekunberri, Itziar; Subirats, Jessica; Borrego, Carles M.; Balcazar, Jose L. (2017). “Exploring the contribution of bacteriophages to antibiotic resistance”. Environmental Pollution220 (Pt B): 981–984. doi:10.1016/j.envpol.2016.11.059. hdl:10256/14115. PMID27890586.
Strauss, James H.; Sinsheimer, Robert L. (July 1963). “Purification and properties of bacteriophage MS2 and of its ribonucleic acid”. Journal of Molecular Biology7 (1): 43–54. doi:10.1016/S0022-2836(63)80017-0. PMID13978804.
Ackermann, H.-W.; Krisch, H. M. (6 April 2014). “A catalogue of T4-type bacteriophages”. Archives of Virology142 (12): 2329–2345. doi:10.1007/s007050050246. PMID9672598.
Lekunberri, Itziar; Subirats, Jessica; Borrego, Carles M.; Balcazar, Jose L. (2017). “Exploring the contribution of bacteriophages to antibiotic resistance”. Environmental Pollution220 (Pt B): 981–984. doi:10.1016/j.envpol.2016.11.059. hdl:10256/14115. PMID27890586.
harvard.edu
ui.adsabs.harvard.edu
Fiers, W.; Contreras, R.; Duerinck, F.; Haegeman, G.; Iserentant, D.; Merregaert, J.; Min Jou, W.; Molemans, F. et al. (1976). “Complete nucleotide sequence of bacteriophage MS2 RNA: primary and secondary structure of the replicase gene”. Nature260 (5551): 500–507. Bibcode: 1976Natur.260..500F. doi:10.1038/260500a0. PMID1264203.
Krishnamurthy SR, Wang D (2018). “Extensive conservation of prokaryotic ribosomal binding sites in known and novel picobirnaviruses”. Virology516: 108–114. doi:10.1016/j.virol.2018.01.006. PMID29346073.
Kutter, Elizabeth; De Vos, Daniel; Gvasalia, Guram; Alavidze, Zemphira; Gogokhia, Lasha; Kuhl, Sarah; Abedon, Stephen (1 January 2010). “Phage Therapy in Clinical Practice: Treatment of Human Infections”. Current Pharmaceutical Biotechnology11 (1): 69–86. doi:10.2174/138920110790725401. PMID20214609.
Rhoads, DD; Wolcott, RD; Kuskowski, MA; Wolcott, BM; Ward, LS; Sulakvelidze, A (June 2009). “Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial”. Journal of Wound Care18 (6): 237–8, 240–3. doi:10.12968/jowc.2009.18.6.42801. PMID19661847.
Wright, A.; Hawkins, C.H.; Änggård, E.E.; Harper, D.R. (August 2009). “A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy”. Clinical Otolaryngology34 (4): 349–357. doi:10.1111/j.1749-4486.2009.01973.x. PMID19673983.
Mokrousov I (2009). “Corynebacterium diphtheriae: genome diversity, population structure and genotyping perspectives”. Infection, Genetics and Evolution9 (1): 1–15. doi:10.1016/j.meegid.2008.09.011. PMID19007916.
Snustad DP. Dominance interactions in Escherichia coli cells mixedly infected with bacteriophage T4D wild-type and amber mutants and their possible implications as to type of gene-product function: catalytic vs. stoichiometric. Virology. 1968 Aug;35(4):550-63. doi: 10.1016/0042-6822(68)90285-7. PMID4878023.
Lekunberri, Itziar; Subirats, Jessica; Borrego, Carles M.; Balcazar, Jose L. (2017). “Exploring the contribution of bacteriophages to antibiotic resistance”. Environmental Pollution220 (Pt B): 981–984. doi:10.1016/j.envpol.2016.11.059. hdl:10256/14115. PMID27890586.
Strauss, James H.; Sinsheimer, Robert L. (July 1963). “Purification and properties of bacteriophage MS2 and of its ribonucleic acid”. Journal of Molecular Biology7 (1): 43–54. doi:10.1016/S0022-2836(63)80017-0. PMID13978804.
Ackermann, H.-W.; Krisch, H. M. (6 April 2014). “A catalogue of T4-type bacteriophages”. Archives of Virology142 (12): 2329–2345. doi:10.1007/s007050050246. PMID9672598.